During the past several years, our study group has repeatedly demonstrated that a low ALT activity in the peripheral blood (measured in international units per liter), representing low muscle mass (sarcopenia), is associated with shortened survival in middle-aged adults [32] and in patients hospitalized for various causes [33,34]. This evidence concerns the gene GPT and sarcopenia.